RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial.

Nat Med · 2024 · PMC10957468 · PMID 38361122

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

A numerically higher decrease in the US effusion score was seen in the denosumab group at week 12 but did not reach statistical significance ( P = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.